Study to Assess Safety and Ability to Induce Immune Responses of HIV-1 Vaccines M3 and M4 Given Alone or in Combination in HIV-infected Adults
Clinical trial NCT03844386 · COMPLETED
Trial details
- NCT number
- NCT03844386
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-22
- Primary completion
- 2021-11-11
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.